研究について

研究について

業績一覧

生化学グループ

  • 2022年（令和4年）
  • Functional AGXT2 SNP rs37369 Variant Is a Risk Factor for Diabetes Mellitus: Baseline Data From the Aidai Cohort Study in Japan. Can J Diabetes. Kumon H, Miyake Y, Yoshino Y, Iga JI, Tanaka K, Senba H, Kimura E, Higaki T, Matsuura B, Kawamoto R, Ueno SI. 2022 Dec;46(8):829-834. doi: 10.1016/j.jcjd.2022.06.004.
  • Blood MAPT expression and methylation status in Alzheimer’s disease. Mori H, Yoshino Y, Ueno M, Funahashi Y, Kumon H, Ozaki Y, Yamazaki Y, Ochi S, Iga J, Ueno S. Psychiatry Clin Neurosci Rep. 2022; 1(4): e65. doi: 10.1002/pcn5.65
  • Association Study and Meta-Analysis of Polymorphisms and Blood mRNA Expression of the ALDH2 Gene in Patients with Alzheimer’s Disease. Ueno M, Yoshino Y, Mori H, Funahashi Y, Kumon H, Ochi S, Ozaki T, Tachibana A, Yoshida T, Shimizu H, Mori T, Iga JI, Ueno SI. Association Study and Meta-Analysis of Polymorphisms and Blood mRNA Expression of the ALDH2 Gene in Patients with Alzheimer’s Disease. J Alzheimers Dis. 2022;87(2):863-871. doi: 10.3233/JAD-215627.
  • Impact of gestational haloperidol exposure on miR-137-3p and Nr3c1 mRNA expression in the hippocampus of offspring mice. Yoshino Y, Kumon H, Shimokawa T, Yano H, Ochi S, Funahashi Y, Iga J, Matsuda S, Tanaka J, Ueno S. Int J Neuropsychopharmacol. 2022 Oct 25;25(10):853-862. doi: 10.1093/ijnp/pyac044.
  • Corticosterone-mediated regulation and functions of miR-218-5p in rat brain. Yoshino Y, Roy B, Dwivedi Y. Sci Rep. 2022 Jan 7;12(1):194. doi: 10.1038/s41598-021-03863-y.
  • Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia. Funahashi Y, Yoshino Y, Iga JI, Ueno SI. World J Biol Psychiatry, 1-11.
  • 2021年（令和3年）
  • PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression. Kumon H, Yoshino Y, Funahashi Y, Mori H, Ueno M, Ozaki Y, Yamazaki K, Ochi S, Mori T, Iga JI, Nagai M, Nomoto M, Ueno SI: J Alzheimers Dis. 2021;79(3):1055-1062. doi: 10.3233/JAD-201046.
  • Blood CDKN2A gene expression in aging and neurodegenerative diseases. Mori H, Funahashi Y, Yoshino Y, Kumon H, Ozaki Y, Yamazaki K, Ochi S, Tachibana A, Yoshida T, Shimizu H, Mori T, Iga JI, Ueno SI: J Alzheimers Dis. 2021;82(4):1737-1744. doi: 10.3233/JAD-210483.
  • 5-HT1A partial agonist tandospirone for behavioral and psychological symptoms in oldest-old patients with dementia at a special elderly nursing home. Ochi S, Mori T, Iga JI, Ueno SI: Clin Psychopharmacol Neurosci. 2021 Aug 31;19(3):514-520. doi: 10.9758/cpn.2021.19.3.514.
  • Neural precursor cells are decreased in the hippocampus of the delayed carbon monoxide encephalopathy rat model. Ochi S, Sekiya K, Abe N, Funahashi Y, Kumon H, Yoshino Y, Nishihara T, Boku S, Iga JI, Ueno SI: Sci Rep. 2021 Mar 18;11(1):6244. doi: 10.1038/s41598-021-85860-9.
  • Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey method. Yoshino Y, Kumon H, Mori T, Yoshida T, Tachibana A, Shimizu H, Iga JI, Ueno SI: BMC Genomics. 2021 Apr 20;22(1):287. doi: 10.1186/s12864-021-07612-3.
  • Molecular pathology associated with altered synaptic transcriptome in the dorsolateral prefrontal cortex of depressed subjects. Yoshino Y, Roy B, Kumar N, Shahid Mukhtar M, Dwivedi Y: Transl Psychiatry. 2021;11(1):73. doi: 10.1038/s41398-020-01159-9.
  • Differential and unique patterns of synaptic miRNA expression in dorsolateral prefrontal cortex of depressed subjects. Yoshino Y, Roy B, Dwivedi Y: Neuropsychopharmacology. 2021 Apr;46(5):900-910. doi: 10.1038/s41386-020-00861-y.
  • ～2020年
  • Identifying Blood Transcriptome Biomarkers of Alzheimer’s Disease Using Transgenic Mice. Ochi S, Iga JI, Funahashi Y, Yoshino Y, Yamazaki K, Kumon H, Mori H, Ozaki Y, Mori T, Ueno SI. Mol Neurobiol. 2020 Dec;57(12):4941-4951. doi: 10.1007/s12035-020-02058-2. Epub 2020 Aug 20.
  • CTLA4 mRNA expression in blood is lower in schizophrenia, but not in affective disorders. Miyamoto K, Funahashi Y, Yoshino Y, Kawabe K, Yamazaki K, Ozaki Y, Mori Y, Ochi S, Iga JI, Ueno SI. Asian J Psychiatr. 2020 Aug;52:102112. doi: 10.1016/j.ajp.2020.102112. Epub 2020 Apr 19.
  • ABCA7 Gene Expression and Genetic Association Study in Schizophrenia. Yamazaki K, Yoshino Y, Kawabe K, Ibuki T, Ochi S, Mori Y, Ozaki Y, Numata S, Iga JI, Ohmori T, Ueno SI. Neuropsychiatr Dis Treat. 2020 Feb 13;16:441-446. doi: 10.2147/NDT.S238471. eCollection 2020.
  • DRD2 methylation to differentiate dementia with Lewy bodies from Parkinson’s disease. Ozaki Y, Yoshino Y, Yamazaki K, Ochi S, Iga JI, Nagai M, Nomoto M, Ueno SI. Acta Neurol Scand. 2020 Feb;141(2):177-182. doi: 10.1111/ane.13186. Epub 2019 Nov 16.
  • Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia. Funahashi Y, Yoshino Y, Yamazaki K, Ozaki Y, Mori Y, Mori T, Ochi S, Iga JI, Ueno SI. Psychiatry Res. 2019 Aug;278:135-140. doi: 10.1016/j.psychres.2019.06.001. Epub 2019 Jun 1.
  • Differential expression of the ghrelin-related mRNAs GHS-R1a, GHS-R1b, and MBOAT4 in Japanese patients with schizophrenia. Nakata S, Yoshino Y, Okita M, Kawabe K, Yamazaki K, Ozaki Y, Mori Y, Ochi S, Iga JI, Ueno SI. Psychiatry Res. 2019 Feb;272:334-339. doi: 10.1016/j.psychres.2018.12.135. Epub 2018 Dec 26.
  • Ghrelin cascade changes in the peripheral blood of Japanese patients with Alzheimer’s disease. Yoshino Y, Funahashi Y, Nakata S, Ozaki Y, Yamazaki K, Yoshida T, Mori T, Mori Y, Ochi S, Iga JI, Ueno SI. J Psychiatr Res. 2018 Dec;107:79-85. doi: 10.1016/j.jpsychires.2018.10.011. Epub 2018 Oct 18.
  • TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer’s Disease. Sao T, Yoshino Y, Yamazaki K, Ozaki Y, Mori Y, Ochi S, Yoshida T, Mori T, Iga JI, Ueno SI. J Alzheimers Dis . 2018;64(4):1275-1284. doi: 10.3233/JAD-180418.
  • MEF2C mRNA expression and cognitive function in Japanese patients with Alzheimer’s disease. Sao T, Yoshino Y, Yamazaki K, Ozaki Y, Mori Y, Ochi S, Yoshida T, Mori T, Iga JI, Ueno SI. Psychiatry Clin Neurosci. 72:160-167, 2018.
  • TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer’s Disease Subjects. Mise A, Yoshino Y, Yamazaki K, Ozaki Y, Sao T, Yoshida T, Mori T, Mori Y, Ochi S, Iga JI, Ueno SI. J Alzheimers Dis. 60: 1107–1117, 2017.
  • DNA Methylation Changes in Intron 1 of Triggering Receptor Expressed on Myeloid Cell 2 in Japanese Schizophrenia Subjects. Yoshino Y, Ozaki Y, Yamazaki K, Sao T, Mori Y, Ochi S, Iga JI, Ueno SI. Front Neurosci. 11: 275, 2017.
  • INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer’s Disease Subjects. Yoshino Y, Yamazaki K, Ozaki Y, Sao T, Yoshida T, Mori T, Mori Y, Ochi S, Iga JI, Ueno SI. J Alzheimers Dis. 58: 687-694, 2017.
  • Elevated mRNA expression of CASPR3 in patients with schizophrenia. Okita M, Yoshino Y, Iga JI, Ueno SI. Nord J Psychiatry 71:312-314, 2017.
  • DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer’s disease. Ozaki Y, Yoshino Y, Yamazaki K, Sao T, Mori Y, Ochi S, Yoshida T, Mori T, Iga JI, Ueno SI. J Psychiatr Res 92:74-80, 2017.
  • Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer’s Disease. Yamazaki K, Yoshino Y, Mori T, Yoshida T, Ozaki Y, Sao T, Mori Y, Ochi S, Iga JI, Ueno SI. J Alzheimers Dis 57: 171-181, 2017.
  • DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies. Funahashi Y, Yoshino Y, Yamazaki K, Mori Y, Mori T, Ozaki Y, Sao T, Ochi S, Iga JI, Ueno SI. Psychiatry Clin Neurosci 71:28-35,2017.

神経心理グループ

  • 2022年（令和4年）
  • Prevalence of comorbid dementia in late-life depression and bipolar disorder: a retrospective inpatient study. Ochi S, Mori T, Iga J, Ueno S. J Alzheimers Dis Rep. 2022 Sep 24;6(1):589-598. doi: 10.3233/ADR-220052.
  • Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer’s disease (from the Nakayama Study). Ozaki T, Yoshino Y, Tachibana A, Shimizu H, Mori T, Nakayama T, Mawatari K, Numata S, Iga JI, Takahashi A, Ohmori T, Ueno SI. Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer’s disease (from the Nakayama Study). Sci Rep. 2022 Sep 8;12(1):15205. doi: 10.1038/s41598-022-19670-y.
  • Secular trends in the prevalence of dementia based on a community-based complete enumeration in Japan: the Nakayama Study. Shimizu H, Mori T, Yoshida T, Tachibana A, Ozaki T, Yoshino Y, Ochi S, Sonobe N, Matsumoto T, Komori K, Iga JI, Ninomiya T, Ueno SI, Ikeda M. Psychogeriatrics. 2022 Sep;22(5):631-641. doi: 10.1111/psyg.12865.
  • ～2020年
  • Study design and baseline characteristics of a population-based prospective cohort study of dementia in Japan: the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD). Ninomiya T, Nakaji S, Maeda T, Yamada M, Mimura M, Nakashima K, Mori T, Takebayashi M, Ohara T, Hata J, Kokubo Y, Uchida K, Taki Y, Kumagai S, Yonemoto K, Yoshida H, Muto K, Momozawa Y, Akiyama M, Kubo M, Ikeda M, Kanba S, Kiyohara Y; JPSFC-AD Study Group. Environ Health Prev Med. 2020 Oct 31;25(1):64. doi: 10.1186/s12199-020-00903-3.
  • Prevalence of possible idiopathic normal pressure hydrocephalus in older inpatients with schizophrenia: a replication study. Yoshino Y, Yoshida T, Morino H, Nakamura M, Abe M, Omachi H, Inoue S, Miyoshi Y, Tachibana Y, Yamauchi N, Takeda N, Mizobuchi M, Ozaki Y, Ochi S, Iga J, Ueno SI. BMC Psychiatry. 2020 Jun 1;20(1):273. doi: 10.1186/s12888-020-02690-1.
  • Improvement of Visuo-spatial Function Assessed by Raven’s Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment. Yoshino Y, Mori T, Yoshida T, Toyota Y, Shimizu H, Iga JI, Nishitani S, Ueno SI. Clin Psychopharmacol Neurosci. 15: 243-247, 2017.

児童青年期精神医学グループ

  • 2022年（令和4年）
  • Expression of overadaptation in children through drawing a man as a projective measure: a community sample study. Horiuchi F, Yoshino-Ozaki A, Hattori H, Hosokawa R, Nakachi K, Ito R, Miyama T, Tachibana Y, Inoue S, Kawabe K, Ueno S. Pediatr Int. 2022 Jan;64(1):e14919. doi: 10.1111/ped.14919.
  • MiR-15b-5p Expression in the Peripheral Blood: A Potential Diagnostic Biomarker of Autism Spectrum Disorder. Brain Sci. Hosokawa R, Yoshino Y, Funahashi Y, Horiuchi F, Iga JI, Ueno SI. 2022 Dec 22;13(1):27. doi: 10.3390/brainsci13010027.
  • Influence of an Esports Program on Problematic Gaming in Children with Autistic Spectrum Disorder: A Pilot Study. Kawabe K, Horiuchi F, Hosokawa R, Nakachi K, Soga J, Ueno SI. Behav Sci (Basel). 2022 May 31;12(6):172. doi: 10.3390/bs12060172.
  • Comorbid symptoms of internet addiction among adolescents with and without autism spectrum disorder: a comparative study. Kawabe K, Horiuchi F, Hosokawa R, Nakachi K, Soga J, Ueno SI. Int J Adolesc Youth. 2022, 27:1, 315-324. doi: 10.1080/02673843.2022.2091939.
  • 2021年（令和3年）
  • Identification of aberrant innate and adaptive immunity based on changes in global gene expression in the blood of adults with autism spectrum disorder. Horiuchi F, Yoshino Y, Kumon H, Hosokawa R, Nakachi K, Kawabe K, Iga JI, Ueno SI: J Neuroinflammation. 2021 Apr 30;18(1):102. doi: 10.1186/s12974-021-02154-7.
  • Mental health and sleep habits/problems in children aged 3-4 years: a population study. Horiuchi F, Kawabe K, Oka Y, Nakachi K, Hosokawa R, Ueno SI: Biopsychosoc Med. 2021 May 20;15(1):10. doi: 10.1186/s13030-021-00213-2.
  • Behavioral Affect in Children with Autism Spectrum Disorder during School Closures Due to the COVID-19 Pandemic in Japan: A Case-Controlled Study. Hosokawa R, Kawabe K, Nakachi K, Yoshino A, Horiuchi F, Ueno SI: Dev Neuropsychol. 2021 Jun 23;1-10. doi: 10.1080/87565641
  • Parent-Adolescent Agreement on Adolescents’ Emotional and Behavioral Problems Assessed by the Strengths and Difficulties Questionnaire. Kawabe K, Horiuchi F, Uno H, Nakachi K, Hosokawa R, Oka Y, Ueno SI: Glob Pediatr Health. 2021 Mar 12;8:2333794X211001245. doi: 10.1177/2333794X211001245. eCollection 2021.
  • Association between Internet Addiction and Application Usage among Junior High School Students: A Field Survey. Kawabe K, Horiuchi F, Hosokawa R, Nakachi K, Ueno SI: Int J Environ Res Public Health. 2021 May 1;18(9):4844. doi: 10.3390/ijerph18094844.
  • Differences in Psychological and Behavioral Changes between Children following School Closure due to COVID-19. Nakachi K, Kawabe K, Hosokawa R, Yoshino A, Horiuchi F, Ueno SI: Psychiatry J. 2021 Aug 21;2021:5567732. doi: 10.1155/2021/5567732. eCollection 2021.
  • ～2020年
  • The Association between Autistic Traits and Sleep Habits/Problems in Toddlers. Horiuchi F, Kawabe K, Oka Y, Nakachi K, Hosokawa R, Ueno SI. Dev Neuropsychol. 2020 Dec 18;45(7-8):485-495. doi: 10.1080/87565641.2020.1865357. Epub 2020 Dec 25.
  • Excessive and Problematic Internet Use During the Coronavirus Disease 2019 School Closure: Comparison Between Japanese Youth With and Without Autism Spectrum Disorder. Kawabe K, Hosokawa R, Nakachi K, Yoshino A, Horiuchi F, Ueno SI. Front Public Health. 2020 Dec 17;8:609347. doi: 10.3389/fpubh.2020.609347. eCollection 2020.
  • Prevalence of Internet addiction in Japan: Comparison of two cross-sectional surveys. Kawabe K, Horiuchi F, Nakachi K, Hosokawa R, Ueno SI. Pediatr Int. 2020 Aug;62(8):970-975. doi: 10.1111/ped.14250. Epub 2020 Jul 28.
  • Sleep Habits and Electronic Media Usage in Japanese Children: A Prospective Comparative Analysis of Preschoolers. Horiuchi F, Oka Y, Kawabe K, Ueno SI. Int J Environ Res Public Health. 2020 Jul 17;17(14):5189. doi: 10.3390/ijerph17145189.
  • Making a brochure about coronavirus disease (COVID-19) for children with autism spectrum disorder and their family members. Kawabe K, Hosokawa R, Nakachi K, Yoshino A, Horiuchi F, Ueno SI. Psychiatry Clin Neurosci. 2020 Sep;74(9):498-499. doi: 10.1111/pcn.13090. Epub 2020 Jul 10.
  • School refusal and bullying in children with autism spectrum disorder. Ochi M, Kawabe K, Ochi S, Miyama T, Horiuchi F, Ueno SI. Child Adolesc Psychiatry Ment Health. 2020 May 7;14:17. doi: 10.1186/s13034-020-00325-7. eCollection 2020.
  • Combination treatment with guanfacine extended release and blonanserin for Tourette’s syndrome comorbid with attention deficit hyperactivity disorder. Kawabe K, Horiuchi F, Ueno SI. Psychiatry Clin Neurosci. 2019 Dec;73(12):762-763. doi: 10.1111/pcn.12935. Epub 2019 Oct 23.
  • Association between Sleep Habits and Problems and Internet Addiction in Adolescents. Kawabe K, Horiuchi F, Oka Y, Ueno SI. Psychiatry Investig. 2019 Aug;16(8):581-587. doi: 10.30773/pi.2019.03.21.2. Epub 2019 Aug 8.
  • Internet addiction and attention-deficit / hyperactivity disorder symptoms in adolescents with autism spectrum disorder. Kawabe K, Horiuchi F, Miyama T, Jogamoto T, Aibara K, Ishii E, Ueno SI. Res Dev Disabil. 2019 Jun;89:22-28. doi: 10.1016/j.ridd.2019.03.002. Epub 2019 Mar 14.
  • Neurocognitive assessment of children with neurodevelopmental disorders: Preliminary findings. Kawabe K, Horiuchi F, Kondo S, Matsumoto M, Seo K, Oka Y, Ueno SI. Pediatr Int. 2018 Sep;60(9):820-827. doi: 10.1111/ped.13662.
  • Suvorexant for the Treatment of Insomnia in Adolescents. Kawabe K, Horiuchi F, Ochi M, Nishimoto K, Ueno SI, Oka Y. J Child Adolesc Psychopharmacol. 27: 792-795, 2017.

その他

  • 2022年（令和4年）
  • Clozapine treatment is associated with higher prescription rate of antipsychotic monotherapy and lower prescription rate of other concomitant psychotropics: A real-world nationwide study. Ochi S, Tagata H, Hasegawa N, Yasui-Furukori N, Iga J, Kashiwagi H, Kodaka F, Komatsu H, Tsuboi T, Tokutani A, Numata S, Ichihashi K, Onitsuka T, Muraoka H, Iida H, Ohi K, Atake K, Kishimoto T, Hori H, Takaesu Y, Takeshima M, Usami M, Makinodan M, Hashimoto N, Fujimoto M, Furihata R, Nagasawa T, Yamada H, Matsumoto J, Miura K, Kido M, Hishimoto A, Ueno S, Watanabe K, Inada K, Hashimoto R. Int J Neuropsychopharmacol. 2022 Oct 25;25(10):818-826. doi: 10.1093/ijnp/pyac036.

日本語文献

  • 2022年（令和4年）
  • 双極性障害・うつ病の多様性と今後．伊賀淳一．精神科 40, 607-614, 2022
  • 子どものうつ病．伊賀淳一．臨牀と研究 99, 555-559, 2022
  • 精神医学における症例報告の意義．上野修一．臨床精神医学 51, 167-172, 2022
  • 卒前教育から生涯教育まで 精神科専攻医教育の課題と今後．上野修一．精神医学 64(7), 991- 998, 2022
  • 感染症疾患に伴う精神障害に対する薬物療法の適応と注意すべき点．越智紳一郎，上野修一．臨床精神薬理 25(8), 885-894, 2022
  • スポーツと不安症．越智紳一郎．臨床精神医学 51(7), 749-753, 2022
  • 成人睡眠障害患者の背景に潜む神経発達症のインパクト-対応を含めて-．河邉憲太郎，堀内史枝，上野修一．精神科治療学 37(1), 75-80, 2022
  • インターネット依存・ゲーム障害の現状と薬物療法の役割．河邉憲太郎．臨床精神薬理 25(3), 267-276, 2022
  • ネット依存，ゲーム障害の現状および予防・介入について．河邉憲太郎．愛媛県小児科医会雑誌 3(1), 32-37, 2022
  • よい睡眠を取るために―中学生．堀内史枝．チャイルドヘルス 25(7), 507-511, 2022
  • 思春期における睡眠の問題および睡眠障害　見立てと治療．堀内史枝．臨床精神薬理 25(3), 305-313, 2022
  • トランスクリプトーム解析による精神障害の解析．吉野祐太．臨床精神医学. 51(10): 1113-1119, 2022
  • 注意欠如・多動症　‐ADHD-の診断・治療ガイドライン．睡眠‐覚醒障害群．堀内史枝．じほう出版．221‐225, 2022
  • 子どものこころと脳 発達のつまずきを支援する．第13章　子どもの睡眠の問題―神経の発達にどう意味をもつのか．堀内史枝、河邉憲太郎．日本評論社．161-171, 2022
  • 2021年（令和3年）
  • 躁病エピソードの正確な診断と鑑別方法 (双極性障害診療を極める)．伊賀淳一．精神科治療学 36 (5), 501-506, 2021
  • ADHD治療薬が睡眠に及ぼす影響．河邉憲太郎，堀内史枝．臨床精神薬理 25(10), 1105-1111, 2022
  • 大うつ病性障害の薬物療法の維持治療：実践的な続け方とやめ方．伊賀 淳一．臨床精神薬理 24 (7), 689-695, 2021
  • バイオマーカーによるうつ病診断への期待．伊賀淳一，吉野祐太，岡山さくら，野津佑真，熊ノ郷頼之，辻川真緒，上野修一．精神科臨床legato 7 (1), 40-43, 2021
  • 「臨床栄養」別冊 はじめてとりくむ妊娠期・授乳期の栄養ケア．7 精神疾患をもつ妊婦の栄養. 河邉憲太郎 ．臨床栄養 2, 171-177, 2021
  • 知らないうちにポテチを食べちゃってました．越智紳一郎．総合診療 31 (6), 755, 2021
  • せん妄における幻視のメカニズム．立花亜由美，森崇明，清水秀明，上野修一．脳神経内科 94 (3), 328-332, 2021
  • 精神障害の将来．伊賀淳一，上野修一．メディカルスタッフのための精神医学．267-272, 2021
  • 認定専門医をめざすために　8．精神・神経疾患．越智紳一郎，河邉憲太郎．病態栄養専門医テキスト改訂第3版：南江堂, 東京: 195-205, 2021
  • 発達障害診療の連携および推進を目的とした愛媛県内の小児科医・精神科医への意識調査．河邉憲太郎, 堀内史枝, 細川里瑛, 仲地究, 上野修一．愛媛医学 40 (3), 143-152, 2021
  • ～2020年
  • 愛媛大学病院精神科外来における成人期発達障害に対する診療パスの予備的研究 河邉憲太郎，越智麻里奈，松本美希，近藤静香，伊藤瑠璃子，芳野歩美，妹尾香苗，堀内史枝，上野修一 精神医学 60巻 5号 Page 545－557 (2018.05)
  • 非寛解うつ病に対して切り替えか，増強かー高齢者の非寛解うつ病で考えておきたいこと 越智紳一郎, 上野修一 臨床精神薬理 20巻 5号 Page 585-588 (2017.05)
  • うつ病維持療法ガイドライン 伊賀淳一 臨床精神薬理 20巻 5号 Page 505-512 (2017.5)
facebook
Return TOP